| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
16,768 |
13,579 |
$605K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,634 |
1,429 |
$80K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,949 |
1,316 |
$30K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,780 |
2,459 |
$29K |
| 86328 |
|
982 |
841 |
$28K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
3,111 |
2,451 |
$26K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
114 |
113 |
$4K |
| 0001A |
|
96 |
90 |
$4K |
| 0071A |
|
120 |
86 |
$4K |
| 0002A |
|
67 |
65 |
$3K |
| 0072A |
|
86 |
68 |
$3K |
| 97169 |
|
113 |
108 |
$3K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
95 |
82 |
$1K |
| 90686 |
|
1,138 |
947 |
$480.61 |
| 90672 |
|
973 |
761 |
$441.82 |
| 90688 |
|
426 |
365 |
$204.96 |
| 81001 |
|
80 |
80 |
$192.74 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
13 |
13 |
$159.45 |
| 90658 |
|
132 |
112 |
$75.30 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,894 |
1,544 |
$10.13 |
| 91300 |
|
218 |
183 |
$0.00 |
| 90685 |
|
70 |
61 |
$0.00 |
| 91307 |
|
203 |
141 |
$0.00 |
| 94760 |
|
20 |
16 |
$0.00 |
| 90657 |
|
22 |
15 |
$0.00 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
21 |
17 |
$0.00 |